Themis Medicare Limited

NSE THEMISMED.NS

Themis Medicare Limited Current Liabilities for the year ending March 31, 2024: USD 18.53 M

Themis Medicare Limited Current Liabilities is USD 18.53 M for the year ending March 31, 2024, a 9.48% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Themis Medicare Limited Current Liabilities for the year ending March 31, 2023 was USD 16.93 M, a 17.36% change year over year.
Themis Medicare Limited Current Liabilities for the year ending March 31, 2022 was USD 14.42 M, a -17.69% change year over year.
Themis Medicare Limited Current Liabilities for the year ending March 31, 2021 was USD 17.52 M, a -14.70% change year over year.
Themis Medicare Limited Current Liabilities for the year ending March 31, 2020 was USD 20.54 M, a -2.68% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

NSE: THEMISMED.NS

Themis Medicare Limited

CEO	Dr. Sachin Dinesh Patel CChem., Ph.D.
IPO Date	April 2, 2007
Location	India
Headquarters	11/12 Udyog Nagar Industrial Estate
Employees	1,509
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.

Key trends

Past 5 years